Viral risks associated with blood transfusion

被引:11
作者
Sloand, EM [1 ]
机构
[1] NHLBI,BETHESDA,MD 20892
关键词
D O I
10.1111/j.1751-1097.1997.tb08583.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Great strides have been made within the last decade to help ensure the safety of the blood supply. Additional tests to detect infectious agents, as well as development of improved donor screening and deferral techniques have helped make the risk of transfusion-transmitted disease very low. Currently, blood banks perform seven tests to detect infectious agents. Prospective donors are carefully questioned about factors that place them at risk for transfusion-transmitted disease and donors known to test positive for certain viruses are permanently deferred, The risks of receiving a human immunodeficiency virus (HIV)-infected unit is now estimated to be 1 in 493000, while the risk of hepatitis B is 1 in 63000. However, changes in prevalence within the blood donor population brought about by changes in the factors that place an individual at risk for a transfusion-transmitted disease could significantly alter these risks. The American public continues to be concerned about the safety of blood transfusion, These concerns coupled with the fears that new viruses or new strains of viruses will be identified that escape detection has created the impetus for development of methods that will remove or inactivate viruses in cellular blood products.
引用
收藏
页码:428 / 431
页数:4
相关论文
共 54 条
[1]   HEPATITIS-C VIRUS-INFECTION IN POSTTRANSFUSION HEPATITIS - AN ANALYSIS WITH 1ST-GENERATION AND 2ND-GENERATION ASSAYS [J].
AACH, RD ;
STEVENS, CE ;
HOLLINGER, FB ;
MOSLEY, JW ;
PETERSON, DA ;
TAYLOR, PE ;
JOHNSON, RG ;
BARBOSA, LH ;
NEMO, GJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (19) :1325-1329
[2]   SERUM ALANINE AMINOTRANSFERASE OF DONORS IN RELATION TO THE RISK OF NON-A,NON-B HEPATITIS IN RECIPIENTS - THE TRANSFUSION-TRANSMITTED VIRUSES STUDY [J].
AACH, RD ;
SZMUNESS, W ;
MOSLEY, JW ;
HOLLINGER, FB ;
KAHN, RA ;
STEVENS, CE ;
EDWARDS, VM ;
WERCH, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (17) :989-994
[3]   DONOR TRANSAMINASE AND RECIPIENT HEPATITIS - IMPACT ON BLOOD-TRANSFUSION SERVICES [J].
ALTER, HJ ;
PURCELL, RH ;
HOLLAND, PV ;
ALLING, DW ;
KOZIOL, DE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1981, 246 (06) :630-634
[4]   CLINICAL AND SEROLOGICAL ANALYSIS OF TRANSFUSION-ASSOCIATED HEPATITIS [J].
ALTER, HJ ;
HOLLAND, PV ;
MORROW, AG ;
PURCELL, RH ;
FEINSTONE, SM ;
MORITSUGU, Y .
LANCET, 1975, 2 (7940) :838-841
[5]   THE USE OF A RECOMBINANT IMMUNOBLOT ASSAY IN THE INTERPRETATION OF ANTI-HEPATITIS-C VIRUS REACTIVITY AMONG PROSPECTIVELY FOLLOWED PATIENTS, IMPLICATED DONORS, AND RANDOM DONORS [J].
ALTER, HJ ;
TEGTMEIER, GE ;
JETT, BW ;
QUAN, S ;
SHIH, JW ;
BAYER, WL ;
POLITO, A .
TRANSFUSION, 1991, 31 (08) :771-776
[6]  
Alter HJ, 1987, TRANSFUSION TRANSMIT, P53
[7]   THE RISK OF TRANSMITTING CYTOMEGALOVIRUS-INFECTION BY FRESH-FROZEN PLASMA [J].
BOWDEN, R ;
SAYERS, M .
TRANSFUSION, 1990, 30 (08) :762-763
[8]  
BOWDEN RA, 1992, BLOOD SAFETY CURRENT, P201
[9]   HEPATITIS-B VIRUS-DNA IN HBSAG-NEGATIVE PATIENTS - MOLECULAR CHARACTERIZATION AND CLINICAL IMPLICATIONS [J].
BRECHOT, C ;
KREMSDORF, D ;
PATERLINI, P ;
THIERS, V .
JOURNAL OF HEPATOLOGY, 1991, 13 :S49-S55
[10]   HEPATITIS-B VIRUS-DNA IN PATIENTS WITH CHRONIC LIVER-DISEASE AND NEGATIVE TESTS FOR HEPATITIS-B SURFACE-ANTIGEN [J].
BRECHOT, C ;
DEGOS, F ;
LUGASSY, C ;
THIERS, V ;
ZAFRANI, S ;
FRANCO, D ;
BISMUTH, H ;
TREPO, C ;
BENHAMOU, JP ;
WANDS, J ;
ISSELBACHER, K ;
TIOLLAIS, P ;
BERTHELOT, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (05) :270-276